New perspectives on MAFLD
Fatty liver disease is a condition characterised by a build-up of fat in the liver and is the most common chronic liver disease that affects over one billion people. Over time, this can lead to complications including cirrhosis, liver failure, liver cancer, and heart health issues. The disease is now known as metabolic (dysfunction) associated fatty liver disease (MAFLD). This is because the disease is now understood to be linked to metabolic factors, such as obesity, insulin resistance, and diabetes. MAFLD is a multisystem disorder with a heterogeneous disease course and outcomes. This means that it can affect multiple organs, and the course of the disease can vary from person ...
Read the release




